REGENOVUE Fine Plus

Regenovue Fine Plus is a low-viscosity dermal filler formulated with 24 mg/ml of cross-linked hyaluronic acid. Its soft and homogeneous gel consistency is designed for addressing superficial wrinkles and fine lines in areas with thinner skin, including periorbital lines, perioral wrinkles, and forehead lines. It can also be used for minor corrections and touch-ups following previous aesthetic treatments.

The product has a monophasic gel structure that supports uniform distribution and controlled injection through fine needles. Its low elasticity and soft consistency make it suitable for precise work in superficial dermal layers while helping preserve natural facial movement. The “Plus” formulation contains 0.3% lidocaine to support greater comfort during the procedure.

Regenovue Fine Plus undergoes a purification process intended to remove residual BDDE and reduce endotoxin levels to below 0.0015 IU/mg. The duration of the result may vary depending on the treatment area, injection depth, individual metabolism, and treatment technique, with effects typically reported for approximately 6–10 months.

Application Areas of Regenovue Fine Plus

Regenovue Fine Plus is intended for professional aesthetic procedures involving superficial wrinkles and fine lines in delicate facial areas.

Main application areas include:

• periorbital lines and crow’s feet;
• perioral and lip wrinkles;
• superficial forehead lines;
• fine lines in areas with thinner skin;
• minor touch-ups after previous filler treatments;
• maintenance procedures for early signs of facial aging.

The appropriate injection technique and treatment area should be determined by a qualified medical professional based on the patient’s individual anatomy and treatment needs.

Strengths of Regenovue Fine Plus

One of the main characteristics of Regenovue Fine Plus is its low-viscosity, monophasic hyaluronic acid gel, which is designed for controlled application in superficial dermal layers. Its homogeneous structure supports even product distribution, while the soft texture and low elasticity are suited to delicate areas where precise correction is required.

Key strengths include:

• 24 mg/ml cross-linked hyaluronic acid;
• low-viscosity monophasic gel;
• homogeneous and smooth consistency;
• suitability for superficial dermal injection;
• 0.3% lidocaine for increased procedure comfort;
• purified formulation with reduced residual BDDE;
• endotoxin content below 0.0015 IU/mg.

The duration and appearance of the result can vary depending on the treated area, injection depth, technique, individual metabolism, and other patient-specific factors. Regenovue Fine Plus should be administered according to the appropriate professional treatment protocol.

Who Regenovue Fine Plus 1×1.1ml Is For

Regenovue Fine Plus is intended for qualified medical and aesthetic professionals who perform dermal filler procedures. Its formulation may be considered for patients requiring subtle correction of superficial lines or maintenance treatments in delicate facial areas.

It can be considered for:

• patients with early signs of facial aging;
• individuals with superficial fine lines;
• treatments targeting periorbital or perioral wrinkles;
• patients requiring minor filler touch-ups;
• maintenance procedures following previous aesthetic treatments;
• professional practitioners performing superficial dermal filler injections.

Regenovue Fine Plus combines low-viscosity cross-linked hyaluronic acid with a soft monophasic gel structure and 0.3% lidocaine. Its formulation is designed for precise treatment of superficial wrinkles and fine lines while supporting controlled product placement in delicate facial areas. The product should be selected and administered by a qualified professional according to the specific treatment protocol.